David Ignatius of the Washington Post on Moscow and President-elect Donald Trump, then, questions for Attorney General nominee Republican Senator Jeff Sessions.
There are an estimated 200 million cases of malaria worldwide each year, and around 600,000 deaths. But the last 15 years represent a success story in the fight against the disease: Increased investment in treatment and prevention have cut the death rate nearly in half. Now, researchers warn that resistance to the primary drug used to treat malaria is spreading. A new study has detected a resistant strain in Myanmar near the Indian border, raising concerns that resistance could soon extend its hold to sub-Saharan Africa, where more than 90 percent of malaria deaths occur. Diane and her guests discuss new concerns about combating malaria worldwide.
- Dr. Alan Magill director of the Malaria Program at the Bill & Melinda Gates Foundation
- Laurie Garrett senior fellow for global health at the Council on Foreign Relations
- Dr. William Moss professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health; co-director of the Southern Africa International Center of Excellence for Malaria Research
- Dr. Lawrence Barat senior technical advisor to the President's Malaria Initiative at USAID
- Jason Beaubien global health and development correspondent for NPR
Most Recent Shows
Maya Angelou came onto this program several times over the years. But in her last conversation with Diane, in 2013, she talked about writing about her fraught relationship with her mother for the first time. Her last words to Diane: “I love you, Diane Rehm. And I look forward to seeing you and talking to you again and again.” A year later, she died at the age of 86. In one of Diane's most treasured interviews, the women reflect on forgiveness, healing and reconciliation.
Mary Chapin Carpenter joins Diane to talk about her new album, the "artistic insight of middle age" and rewriting her life story in new ways.
A rebroadcast of Diane's 1999 interview with J.K. Rowling, author of the acclaimed Harry Potter series.